Results 1 to 10 of about 154,726 (192)

Cyclophosphamide [PDF]

open access: greenBMJ, 1963
Cyclophosphamide, a recently-developed alkylating agent that may be administered orally, intramuscularly, and intravenously, was given to 135 patients with a wide variety of malignant diseases. Significant benefit was obtained in patients with lymphomas and leukemias as well as malignant melanoma, multiple myeloma, and carcinoma of the ovaries ...
G. Hamilton Fairley
  +7 more sources

Post-transplant cyclophosphamide-induced cardiotoxicity: A comprehensive review [PDF]

open access: yesJournal of Cardiovascular and Thoracic Research
Cyclophosphamide-induced cardiotoxicity, associated with its toxic metabolite acrolein, is a significant concern and unresolved issue, especially when cyclophosphamide is administrated in high doses.
Azin Alizadehasl   +9 more
doaj   +2 more sources

Cyclophosphamide and the kidney [PDF]

open access: bronzeCancer, 1974
The effect of cyclophosphamide on renal function was studied in 17 normally hydrated patients with cancer. No nephrotoxic effects were observed. High-dose cyclophosphamide (⩾50 mg/kg body weight) did, however, impair water excretion as manifested by weight gain, hyponatremia, and inappropriately concentrated urine.
Ralph A. DeFronzo   +4 more
openalex   +3 more sources

Fish oil enhanced the efficacy of low-dose cyclophosphamide regimen for proliferative lupus nephritis: a randomized controlled double-blind trial

open access: yesFood & Nutrition Research, 2021
Background: Lupus nephritis (LN) is one of the most severe organ that damages the systemic lupus erythematosus (SLE). Cyclophosphamide is one of the main drugs used in the treatment of LN.
Chi Zhang   +3 more
doaj   +1 more source

Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation. [PDF]

open access: yesPLoS ONE, 2015
Cyclophosphamide is commonly used as an important component in conditioning prior to hematopoietic stem cell transplantation, a curative treatment for several hematological diseases.
Ibrahim El-Serafi   +4 more
doaj   +1 more source

Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population

open access: yesPharmaceuticals, 2021
Infants and young children represent an important but much understudied childhood cancer patient population. The pharmacokinetics and pharmacogenetics of the widely used anticancer prodrug cyclophosphamide were investigated in children
Shelby Barnett   +6 more
doaj   +1 more source

A Study on the Alteration of Endoplasmic Reticulum Stress-related Proteins in Cyclophosphamide-induced Damage to Urothelium [PDF]

open access: yesPharmaceutical and Biomedical Research, 2023
Background: Cyclophosphamide is widely prescribed as an anti-cancer drug and used as an immunosuppressant. Hemorrhagic cystitis is one of the common complications of cyclophosphamide intake.
Hemalatha R   +3 more
doaj  

The therapeutic effects of curcumin and capsaicin against cyclophosphamide side effects on the uterus in rats [PDF]

open access: yesActa Cirúrgica Brasileira, 2018
Purpose: To evaluate the impact of systemic cyclophosphamide treatment on the rat uterus and investigate the potential therapeutic effects of natural antioxidant preparations curcumin and capsaicin against cyclophosphamide side effects.
Ercan Yilmaz   +5 more
doaj   +1 more source

Nephrotoxicity Risk of Cyclophosphamide in Lupus Model

open access: yesJournal of Tropical Pharmacy and Chemistry, 2021
Cyclophosphamide is one of the standard therapies for lupus, especially lupus nephritis based on its immunosuppressive effect. However, cyclophosphamide is also known as a nephrotoxic agent.
Niken Indriyanti
doaj   +1 more source

Home - About - Disclaimer - Privacy